Saratoga, CA – June 20, 2022 – CapsoVision, an innovator in the gastroenterology diagnostics market, and Gastrologix working in conjunction with the Digestive Health Network (DHN), the only gastroenterology specific group purchasing organization (GPO) in the United States, have announced an agreement designating CapsoVision as the primary supplier of capsule endoscopy imaging solutions. CapsoVision will offer CapsoCam Plus®, the only small bowel capsule endoscopy system in the world with a 360° panoramic view, to hundreds of the gastroenterology offices and clinical end users served by Gastrologix across the United States.
CapsoCam Plus is cleared by the United States Food and Drug Administration and serves as a valuable tool in the detection of abnormalities of the small bowel by offering a full panoramic, direct lateral view of the small bowel mucosa. High resolution and 15-hour battery life provide the most comprehensive imaging available today. More detailed imaging by CapsoCam Plus may allow for greater diagnostic yield and its use of a large-capacity, on-board storage system eliminates the need for external receiver equipment. Cloud-based, HIPAA-compliant capsule endoscopy software provides easy access to a patient’s secure exam data, improving convenience for both patients and gastroenterology practices.
“We’re honored to partner with Gastrologix, a true leader in providing technology and practice management solutions with a 100 percent focus on gastroenterology offices around the United States,” said Johnny Wang, president and CEO of CapsoVision. “Gastrologix has a long history of providing operational and financial impact throughout the GI industry. By leveraging CapsoCam Plus, its entire gastroenterology specific group purchasing organization will have the opportunity to help improve patient outcomes, convenience, and satisfaction.”
“We are dedicated to helping independent GI practices lower costs, operate more efficiently, and expand their services,” said Stephen Somers, principal at Gastrologix. “By providing access to CapsoCam Plus by CapsoVision, our network of independent practices providing high-quality GI care will now have access to a small bowel capsule endoscope offering unparalleled comfort, convenience, and freedom to patients. By partnering with CapsoVision, our network will be able to see more and do more as a result of the improved diagnostic capabilities offered by CapsoCam and its full 360º panoramic, direct lateral view of the small bowel.”
“It’s valuable partnerships like the one formed with Gastrologix that ultimately empower physicians and patients,” said Wang. “Through innovative technologies we are working together to improve diagnostic confidence and clinical outcomes for everyone. This is what drives us every day at CapsoVision as we work with other leaders in digestive health to define the future of diagnostic imaging.”
Founded in 2006, CapsoVision is a Silicon Valley, global medical device innovator specializing in diagnostic imaging of the gastrointestinal system. Through our world-class talent and out-of-the-box thinking, we strive to empower physicians and patients by developing innovative technologies, which provide superior clinical outcomes and improve patient quality of life. Our flagship CapsoCam Plus small bowel capsule endoscope uses a novel 360° panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort, convenience, and freedom to patients. For more about CapsoCam Plus, visit www.capsovision.com.
Gastrologix is the only Group Purchasing Organization (GPO) in the U.S. working strictly on behalf of independent gastroenterologists. Gastrologix helps practices lower costs, operate more efficiently, and expand services, so that GI physicians can remain independent to provide a valuable healthcare alternative. Information about Gastrologix is available at www.gastrologix.net.